Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?

scientific article published on 01 August 2006

Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-3148.2006.00672.X
P698PubMed publication ID16879155

P2093author name stringSeitz R
Heiden M
Hunfeld A
Breitner-Ruddock S
Salge-Bartels U
P433issue4
P304page(s)266-275
P577publication date2006-08-01
P1433published inTransfusion MedicineQ15758505
P1476titleAre quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?
P478volume16

Reverse relations

cites work (P2860)
Q37776318A comparison of methods of pathogen inactivation of FFP
Q37715077Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality
Q34777948Chemical and biological mechanisms of pathogen reduction technologies
Q30152155Comprehensive US government program for dried plasma development
Q37201179Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
Q42751781Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma
Q37207560Pathogen reduction of blood components
Q37026225Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies
Q50787426Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.
Q24315760Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability
Q37209117Recommendations for the transfusion of plasma and platelets
Q37062415Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma
Q38213153Solvent/detergent plasma: pharmaceutical characteristics and clinical experience
Q35095666The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma
Q39230229Therapeutic plasmas available worldwide
Q41869417Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System
Q46045568Transfusion and allergy
Q35040142Universal pathogen-reduced plasma in elective open-heart surgery and liver resection

Search more.